Nuo Therapeutics, Inc. (NUOT) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 17 transactions totaling $299.9K, demonstrating a bearish sentiment with -$299.9K in net insider flow. The most recent transaction on May 11, 2015 involved a sale of 50,000 shares valued at $13.5K.
No significant insider buying has been recorded for NUOT in the recent period.
No significant insider selling has been recorded for NUOT in the recent period.
Based on recent SEC filings, insider sentiment for NUOT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$299.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Nuo Therapeutics, Inc. (NUOT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading NUOT stock, having executed 17 transactions in the past 90 days. The most active insider is William W. Brooke (Executive), who has made 12 transactions totaling $1.7M.
Get notified when executives and directors at NUOT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 11, 2015 | Llc Aldagen Holdings, | Executive | Sale | 50,000 | $0.27 | $13.5K | |
| Jan 20, 2015 | Llc Aldagen Holdings, | Executive | Sale | 5,500 | $0.35 | $1.9K | |
| Jan 14, 2015 | W. Brooke William | Executive | Sale | 153,467 | $0.35 | $53.7K | |
| Jan 13, 2015 | W. Brooke William | Executive | Sale | 14,000 | $0.35 | $4.9K | |
| Jan 12, 2015 | W. Brooke William | Executive | Sale | 73,496 | $0.35 | $25.7K | |
| Jan 9, 2015 | W. Brooke William | Executive | Sale | 61,037 | $0.35 | $21.4K | |
| Jan 9, 2015 | W. Brooke William | Executive | Sale | 15,850 | $0.35 | $5.5K | |
| Jan 8, 2015 | W. Brooke William | Executive | Sale | 82,850 | $0.35 | $29.0K | |
| Dec 31, 2014 | W. Brooke William | Executive | Sale | 100 | $0.35 | $35 | |
| Dec 30, 2014 | W. Brooke William | Executive | Sale | 1,200 | $0.35 | $420 | |
| Dec 30, 2014 | W. Brooke William | Executive | Sale | 299,900 | $0.35 | $105.0K | |
| Dec 29, 2014 | W. Brooke William | Executive | Sale | 100 | $0.35 | $35 | |
| Dec 22, 2014 | Jefferson Clark B. | Executive | Sale | 10,300 | $0.37 | $3.8K | |
| Dec 19, 2014 | Jefferson Clark B. | Executive | Sale | 97,150 | $0.35 | $34.0K | |
| Nov 28, 2014 | Jefferson Clark B. | Executive | Sale | 2,850 | $0.35 | $998 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 2 | $1.5M | 83.3% |
Sale(S) | 15 | $299.9K | 16.7% |
Insider selling pressure at Nuo Therapeutics, Inc. has increased, with 3 insiders executing 17 transactions across all time. Total sales of $299.9K significantly outpace purchases of $0, resulting in a net outflow of $299.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.